Literature DB >> 19341701

(Pre)analytical imprecision, between-subject variability, and daily variations in serum and urine hepcidin: implications for clinical studies.

Joyce J C Kroot1, Jan C M Hendriks, Coby M M Laarakkers, Siem M Klaver, Erwin H J M Kemna, Harold Tjalsma, Dorine W Swinkels.   

Abstract

The utility of urine and serum hepcidin measurements in the clinic depends on their reproducibility. We sought to expand our previous work on the within-subject variability and between-subject variability of this novel iron parameter in the serum and urine of 24 healthy controls by time-of-flight mass spectrometry at four different time points during the day. A linear mixed model for repeated data was used to distinguish three components of the total variability in the measurements: within-day/within-subject variability, between-subject variability, and additional residual or (pre)analytical variability. Differences in diurnal hepcidin patterns were observed between urine and serum. Urine levels remained similar during the course of the morning and increased significantly during the afternoon, whereas serum levels increased significantly throughout both the morning and afternoon. Furthermore, in serum the (pre)analytical variability (28.6%) was smaller than the between-subject (48.1%) and within-day/within-subject variability (30.3%) compared with urine variability (97.2% vs. 67.7 and 77.3%, respectively). High serum ferritin levels were associated with higher serum hepcidin levels but not with urine levels. Transferrin saturation did not correlate with hepcidin levels. To minimize variability, we recommend (i) standardizing for sampling time and (ii) measuring serum hepcidin levels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19341701     DOI: 10.1016/j.ab.2009.03.039

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  32 in total

1.  Afebrile Plasmodium falciparum parasitemia decreases absorption of fortification iron but does not affect systemic iron utilization: a double stable-isotope study in young Beninese women.

Authors:  Colin I Cercamondi; Ines M Egli; Ella Ahouandjinou; Romain Dossa; Christophe Zeder; Lamidhi Salami; Harold Tjalsma; Erwin Wiegerinck; Toshihiko Tanno; Richard F Hurrell; Joseph Hounhouigan; Michael B Zimmermann
Journal:  Am J Clin Nutr       Date:  2010-10-06       Impact factor: 7.045

2.  Immunoassay-based serum hepcidin reference range measurements in healthy children: differences among age groups.

Authors:  Triantafyllia Sdogou; Charalampos Tsentidis; Dimitrios Gourgiotis; Antonios Marmarinos; Alexandra Gkourogianni; Ioannis Papassotiriou; Theodora Anastasiou; Lydia Kossiva
Journal:  J Clin Lab Anal       Date:  2014-03-22       Impact factor: 2.352

Review 3.  Genetic variation in hepcidin expression and its implications for phenotypic differences in iron metabolism.

Authors:  Henry K Bayele; Surjit Kaila S Srai
Journal:  Haematologica       Date:  2009-09       Impact factor: 9.941

4.  Evaluation of serum markers for improved detection of autologous blood transfusions.

Authors:  Holly D Cox; Geoffrey D Miller; Auriella Lai; Dan Cushman; Tomas Ganz; Daniel Eichner
Journal:  Haematologica       Date:  2018-04-19       Impact factor: 9.941

5.  A novel monoclonal antibody immunoassay for the detection of human serum hepcidin.

Authors:  Peggy Schwarz; Pavel Strnad; Guido von Figura; Alfred Janetzko; Pierre Krayenbühl; Guido Adler; Hasan Kulaksiz
Journal:  J Gastroenterol       Date:  2010-12-07       Impact factor: 7.527

6.  Hepcidin in anemia of chronic heart failure.

Authors:  Vijay Divakaran; Sachin Mehta; David Yao; Saamir Hassan; Steven Simpson; Erwin Wiegerinck; Dorine W Swinkels; Douglas L Mann; Vahid Afshar-Kharghan
Journal:  Am J Hematol       Date:  2011-01       Impact factor: 10.047

7.  Iron homeostasis in mother and child during placental malaria infection.

Authors:  Susanne Van Santen; Quirijn de Mast; Adrian J F Luty; Erwin T Wiegerinck; Andre J A M Van der Ven; Dorine W Swinkels
Journal:  Am J Trop Med Hyg       Date:  2011-01       Impact factor: 2.345

8.  Reduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidin.

Authors:  Sergei Nekhai; Min Xu; Altreisha Foster; Ishmael Kasvosve; Sharmin Diaz; Roberto F Machado; Oswaldo L Castro; Gregory J Kato; James G Taylor; Victor R Gordeuk
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

9.  Plasma hepcidin levels and anemia in old age. The Leiden 85-Plus Study.

Authors:  Wendy P J den Elzen; Anton J M de Craen; Erwin T Wiegerinck; Rudi G J Westendorp; Dorine W Swinkels; Jacobijn Gussekloo
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

10.  Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias.

Authors:  Elizabeta Nemeth
Journal:  Adv Hematol       Date:  2009-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.